The Safety of Bisphosphonates for Primary Osteoporosis: An Overview of Systematic Reviews and Meta-analysis
Journal Title: Journal of Pharmaceutical and Biomedical Sciences - Year 2017, Vol 7, Issue 10
Abstract
Introduction Bisphosphonates (BPs) are the first-line therapy for osteoporosis, especially primary osteoporosis, but many systematic reviews exist with conflicting conclusions about the safety of BPs. We performed an overview of systematic reviews to evaluate the risk of adverse events of BPs used in primary osteoporosis. Methods We identified systematic reviews with meta-analyses of RCTs published in English that evaluated the safety of BPs. Data sources used include the Cochrane library, PubMed, the Web of Science and hand-searching of reference lists. A standardized form was used for data extraction. The methodological quality of each systematic review was assessed by two reviewers using the AMSTAR tool, and the quality of evidence for adverse events was assessed using the GRADE approach. We made a new meta-analysis for the primary outcomes as the conflicting results of the original systematic reviews. Results 1362 potentially relevant citations were identified, of which only 15 systematic reviews with meta-analyses met the eligibility criteria. All included reviews were published between 2009 and 2016, and documented the pooled estimates of RR or OR and their 95% CI for the incidence of adverse events. The median AMSTAR score was 9. The majority of the quality of evidence for safety outcomes in the findings judged as low even very low quality, but in our new meta-analysis judged as moderate or high quality. Conclusions This overview provides a comprehensive assessment on the safety of BPs. In our meta-analysis, BPs significantly increased the risk of atrial fibrillation and serious atrial fibrillation when compared with placebo or other anti-osteoporosis drug, but did not significantly increase the risk of gastrointestinal events, stroke, cardiovascular death, atypical fracture or fracture union. The risk of atypical fracture and fracture union of BPs used needs further research.
Authors and Affiliations
Jian Li, Liqing Lu, Yongchang Chen, Jianping Zhang
Keywords
Related Articles
- EP ID EP311974
- DOI -
- Views 83
- Downloads 0
Comparative Study of Functional Outcome in Colles’ Fracture Treated Conservatively by Closed Reduction and Cast and Closed Reduction, Kirschner Wire and Cast
Displaced Colles’ fractures are generally treated by closed reduction and below elbow cast application. Malunion is a common complication resulting in pain, mid carpal instability and post-traumatic arthritis. Fracture s...
Revisiting the Utility of Biochemical Profile in the Diagnosis and Management of Hepatitis C Virus Infection: a Study from India
Several serum analytes can be used for the management of liver diseases. The present study was carried out to assess the role of biochemical markers in the diagnosis and prognosis of HCV infection. Blood samples (5 ml) c...
Optimum Initiating Pressure of Nasal CPAP in Newborns with Moderate Respiratory Distress: A Randomised Controlled Trial
Objective To decide the optimum initiating pressure of nasal CPAP in newborns with respiratory distress. Methods The study was done in neonatal intensive care unit (NICU) between November 2009 and November 2011 as a pros...
Effects of Chicken Extract on the Serotonergic System of Mice Loaded with Restraint Stress
Chicken extract (CE), which is composed of water-soluble substances extracted from chicken by double boiling, could enhance mental efficiency and are helpful to the recovery from postpartum sickness and mental fatigue. B...
Cardioprotection of a Novel Danshensu Derivate Against Oxidative Injury and Mitochondrial Dysfunction in Vitro and Myocardial Ischemia/Reperfusion Injury in Rat
Objectives Myocardial ischemia/reperfusion injury remains an important clinical problem in the world. Extensive research have focused on strategies for attenuating myocardial ischemia and reperfusion injury. Danshensu (D...